IFU
CRL icon

iSAM Funds (UK)’s Charles River Laboratories CRL Stock Holding History

iSAM Funds (UK)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,375
Closed -$528K – 404
2025
Q3 		$528K Buy
+3,375
New +$536K 0.11% 264
2024
Q3 		– Sell
-2,245
Closed -$464K – 315
2024
Q2 		$464K Buy
+2,245
New +$509K 0.35% 105

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

iSAM Funds (UK)'s CRL Position: Q4 2025 in Review

iSAM Funds (UK) sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 3,375 shares — an estimated $528K sold.

iSAM Funds (UK) first reported a position in CRL in Q2 2024 and held it in 2 quarters. The position peaked at $528K in Q3 2025. 582 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • iSAM Funds (UK) reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • iSAM Funds (UK) sold 3,375 Charles River Laboratories shares in Q4 2025, an estimated $528K.
  • iSAM Funds (UK) first reported a position in Charles River Laboratories in Q2 2024 and held it in 2 quarters.
  • iSAM Funds (UK)'s Charles River Laboratories position peaked at $528K in Q3 2025.
  • 582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on iSAM Funds (UK)'s 13F filing for Q4 2025, filed 17 Feb 2026.